Collegium Pharmaceutical (COLL)
(Delayed Data from NSDQ)
$40.91 USD
+0.98 (2.45%)
Updated Mar 27, 2024 04:00 PM ET
After-Market: $40.91 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $1.50 | 1.83% |
Earnings Summary
For their last quarter, Collegium Pharmaceutical (COLL) reported earnings of $1.58 per share, beating the Zacks Consensus Estimate of $1.33 per share. This reflects a positive earnings surprise of 18.80%. Look out for COLL's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of $1.50 per share, reflecting a year-over-year increase of 13.64%.
Earnings History
Price & Consensus
Zacks News for COLL
Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now?
COLL: What are Zacks experts saying now?
Zacks Private Portfolio Services